Liphorus Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2014
Total raised
- $6.4M
Investors
- 1
About Liphorus Pharmaceuticals
Liphorus Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutic solutions to meet healthcare challenges.Founded in 2014, Liphorus Pharmaceuticals is based in Montreal, Canada. The company specializes in developing biopharmaceutical products aimed at improving health outcomes.Liphorus Pharmaceuticals specializes in providing innovative therapeutic solutions designed to address specific health challenges. Their core product offerings include a range of biopharmaceutical therapies that target various medical conditions, enhancing treatment efficacy and patient engagement. These solutions are tailored to meet the needs of healthcare providers and patients, allowing for optimized treatment regimens and improved health outcomes.The company generates revenue primarily through a subscription-based model, wherein clients pay a recurring fee to access their therapeutic solutions and updates. Typical transactions involve healthcare providers entering into annual contracts that ensure continuous access to the necessary treatment tools. The pricing structure accommodates various client needs, resulting in tiered plans that cater to different scales of use and therapeutic options. Flagship products drive significant revenue streams, attracting both direct-to-consumer and B2B clients.Liphorus Pharmaceuticals is planning to launch new therapeutic products designed to address additional health conditions, with anticipated release dates aligned with ongoing clinical development timelines. The company aims to expand its presence into European and Asian markets by 2025, focusing on regions with high unmet medical needs.4 mn will be utilized to support research and development of these new products as well as to facilitate market entry strategies in the targeted regions.
Who invested in Liphorus Pharmaceuticals
1 investor across 1 round
See all investors in Liphorus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 6, 2014
Amount
$6.4M
Investors
Questions about Liphorus Pharmaceuticals
Who invested in Liphorus Pharmaceuticals?
Liphorus Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Liphorus Pharmaceuticals raised?
Liphorus Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Liphorus Pharmaceuticals last raise money?
Liphorus Pharmaceuticals's most recent round on record is a Series A, in Nov 2014.
What does Liphorus Pharmaceuticals do?
Liphorus Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutic solutions to meet healthcare challenges.
Where is Liphorus Pharmaceuticals headquartered?
Liphorus Pharmaceuticals is headquartered in Montreal, Canada.
Which VCs invest in companies like Liphorus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Liphorus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Liphorus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.